Price$4.00-0.00 (-0.12%)
02:30 PM07:45 PM
News · 26 weeks52+233%
2025-12-142026-06-07
Mix3390d
- Insider19(58%)
- SEC Filings8(24%)
- Earnings3(9%)
- Other2(6%)
- Leadership1(3%)
Latest news
25 items- SECKORU Medical Systems Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - KORU Medical Systems, Inc. (0000704440) (Filer)
- INSIDERChief Technology Officer Schiller Eric bought $19,562 worth of shares (5,000 units at $3.91) (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERAmendment: Chief Executive Officer Tharby Linda M bought $4,669 worth of shares (1,191 units at $3.92), increasing direct ownership by 0.19% to 620,622 units (SEC Form 4)4/A - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERChief Executive Officer Tharby Linda M bought $1,418,481 worth of shares (1,191 units at $1,191.00), increasing direct ownership by 0.19% to 620,622 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERChief Executive Officer Tharby Linda M converted options into 13,977 shares and covered exercise/tax liability with 7,326 shares, increasing direct ownership by 1% to 619,431 units (SEC Form 4) (for withholding tax)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERChief Operating Officer Pazdan Christopher converted options into 5,327 shares and covered exercise/tax liability with 1,470 shares, increasing direct ownership by 1% to 308,988 units (SEC Form 4) to cover withholding tax4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERChief Operating Officer Pazdan Christopher bought $19,400 worth of shares (5,000 units at $3.88), increasing direct ownership by 2% to 305,131 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERChief Financial Officer Adams Thomas Edward converted options into 8,193 shares and covered exercise/tax liability with 2,900 shares, increasing direct ownership by 2% to 313,440 units (SEC Form 4) to cover taxes4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERChief Financial Officer Adams Thomas Edward bought $21,248 worth of shares (5,500 units at $3.86), increasing direct ownership by 2% to 308,147 units (SEC Form 4)4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- PRKORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society CongressKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company presented its latest research at the Oncology Nursing Society (ONS) Congress, May 13-17. The poster at ONS was titled, "Reducing Ergonomic Strain During Subcutaneous Monoclonal Antibody Administration." The ONS abstract evaluated nursing workflow, nurse experience, and patient-reported outcomes after implementing KORU Medical's FreedomEDGE® infusion system for subcutaneous drug administration across four community infusion centers in the United States. The fi
- PRKORU Medical Systems Announces First Quarter 2026 ResultsKORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the first quarter ended March 31, 2026. The Company also reiterated guidance for the full year 2026. Recent Highlights First quarter 2026 net revenues of $11.8 million grew 22% over the prior year period First quarter 2026 gross profit grew 20% over the prior year period to $7.2 million, with gross margin of 61.5% First quarter 2026 net loss improved 31% to ($0.8) million Ending cash bal
- SECSEC Form 10-Q filed by KORU Medical Systems Inc.10-Q - KORU Medical Systems, Inc. (0000704440) (Filer)
- SECKORU Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - KORU Medical Systems, Inc. (0000704440) (Filer)
- PRKORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report first quarter 2026 financial results on Wednesday, May 6, 2026. KORU Medical's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Conference Call and Webcast Details The conference call can be accessed by dialing (877)-407-0784 for participants in the U.S. or Canada and (201)-689-8560 for international ca
- SECSEC Form DEF 14A filed by KORU Medical Systems Inc.DEF 14A - KORU Medical Systems, Inc. (0000704440) (Filer)
- INSIDERAmendment: SEC Form 4 filed by Manko Joseph M. Jr.4/A - KORU Medical Systems, Inc. (0000704440) (Issuer)
- SECKORU Medical Systems Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - KORU Medical Systems, Inc. (0000704440) (Filer)
- INSIDERSEC Form 4 filed by Wholihan Edward4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERSEC Form 4 filed by Cascella Robert4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERSEC Form 4 filed by French Donna4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERSEC Form 4 filed by Matin Shahriar4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERSEC Form 4 filed by Fletcher R John4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERSEC Form 4 filed by Manko Joseph M. Jr.4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERSEC Form 4 filed by Kalbermatten Adam R4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
- INSIDERSEC Form 4 filed by Pazdan Christopher4 - KORU Medical Systems, Inc. (0000704440) (Issuer)
KRMD FAQ
6 questionsWhat does KORU Medical Systems Inc. do?
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales...Where does KRMD stock trade?
KORU Medical Systems Inc. (KRMD) is listed on NASDAQ.What sector and industry is KRMD in?
KORU Medical Systems Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about KRMD?
KORU Medical Systems Inc. has had 6 recent analyst actions on file. The most recent action was from Piper Sandler: Neutral with a $450.00 price target on 2025-02-14. Recent price targets range from $350.00 to $450.00.What companies are similar to KRMD?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare KRMD side-by-side with any of them on Quantisnow.How can I track KRMD on Quantisnow?
Quantisnow aggregates KORU Medical Systems Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow KRMD to receive live email and push alerts on every new disclosure.